Trial
NCT02090998
Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Rutgers, The State University of New Jersey
Collaborators
—
Condition
Transformed Migraine
Intervention
SPG Block with 5% Lidocaine gel
Why stopped
no patients during covid pandemic
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-23